Genentech requests that their press release NewsItemId: 20240125093104 “New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)” be killed.
The release was issued prematurely by Genentech.
A replacement release will be issued at a later date.
Contacts
Media Contact:
Shirley Dang, (650) 467-6800
Advocacy Contact:
Danielle Haney, (240) 805-4810
Investor Contacts:
Loren Kalm, (650) 225-3217
Bruno Eschli, +41 61 687 5284
